Bacteriophages: an overview of the control strategies against multiple bacterial infections in different fields.


Journal

Journal of basic microbiology
ISSN: 1521-4028
Titre abrégé: J Basic Microbiol
Pays: Germany
ID NLM: 8503885

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 05 08 2018
revised: 24 10 2018
accepted: 31 10 2018
pubmed: 30 11 2018
medline: 23 2 2019
entrez: 29 11 2018
Statut: ppublish

Résumé

Bacteriophages (phages/viruses) need host bacteria to replicate and propagate. Primarily, a bacteriophage contains a head/capsid to encapsidate the genetic material. Some phages contain tails. Phages encode endolysins to hydrolyze bacterial cell wall. The two main classes of phages are lytic or virulent and lysogenic or temperate. In comparison with antibiotics, to deal with bacterial infections, phage therapy is thought to be more effective. In 1921, the use of phages against bacterial infections was first demonstrated. Later on, in humans, phage therapy was used to treat skin infections caused by Pseudomonas species. Furthermore, phages were successfully employed against infections in animals - calves, lambs, and pigs infected with Escherichia coli. In agriculture, for instance, phages have successfully been used e.g., Apple blossom infection, caused by Erwinia amylovora, was effectively catered with the use of bacteriophages. Bacteriophages were also used to control E. coli, Salmonella, Listeria, and Campylobacter contamination in food. Comparatively, phage display is a recently discovered technology, whereby, bacteriophages play a significant role. This review is an effort to collect almost recent and relevant information regarding applications and complications associated with the use of bacteriophages.

Identifiants

pubmed: 30485461
doi: 10.1002/jobm.201800412
doi:

Substances chimiques

Anti-Bacterial Agents 0
DNA, Viral 0

Types de publication

Historical Article Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

123-133

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Auteurs

Muhsin Jamal (M)

Department of Microbiology, Abdul Wali Khan University, Garden Campus, Mardan, Pakistan.

Sayed M A U S Bukhari (SMAUS)

Department of Microbiology, Abdul Wali Khan University, Garden Campus, Mardan, Pakistan.

Saadia Andleeb (S)

Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan.

Muhammad Ali (M)

Department of Life Sciences, School of Science, University of Management and Technology (UMT), Lahore, Pakistan.

Sana Raza (S)

Institute of Health Sciences, Mardan, Pakistan.

Muhammad A Nawaz (MA)

Department of Biotechnology, Shaheed Benazir Bhutto University, Sheringal, Dir (Upper), Pakistan.

Tahir Hussain (T)

Department of Microbiology, Abdul Wali Khan University, Garden Campus, Mardan, Pakistan.

Sadeeq U Rahman (SU)

College of Veterinary Sciences and Animal Husbandry, Abdul Wali Khan University, Garden Campus, Mardan, Pakistan.

Syed S A Shah (SSA)

Department of Zoology, Abdul Wali Khan University, Garden Campus, Mardan, Pakistan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH